Holen Sie sich die Stockscreener-App
4.025
0.38%
0.035
Schlusskurs vom Vortag:
$3.99
Offen:
$4.04
24-Stunden-Volumen:
369.72K
Relative Volume:
0.04
Marktkapitalisierung:
$2.41B
Einnahmen:
$237.00K
Nettoeinkommen (Verlust:
$-184.13M
KGV:
-11.84
EPS:
-0.34
Netto-Cashflow:
$-168.57M
1W Leistung:
+7.95%
1M Leistung:
+1.39%
6M Leistung:
+8.24%
1J Leistung:
+108.59%
1-Tages-Spanne:
$3.96
$4.05
1-Wochen-Bereich:
$3.60
$4.05
52-Wochen-Spanne:
$1.64
$5.34
Geron Corp Stock (GERN) Company Profile
Firmenname
Geron Corp
Sektor
Branche
Telefon
(650) 473-7700
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Vergleichen Sie GERN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| GERN | 4.02 | 2.41B | 237.00K | -184.13M | -168.57M | -0.34 |
| VRTX | 447.95 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.90 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.67 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.92 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.56 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-09 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | Eingeleitet | TD Cowen | Buy |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2023-09-12 | Hochstufung | Goldman | Neutral → Buy |
| 2023-03-28 | Eingeleitet | Goldman | Neutral |
| 2022-10-28 | Eingeleitet | Wedbush | Outperform |
| 2022-07-28 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-11-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2020-08-03 | Eingeleitet | Stifel | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-09-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-08-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-04-09 | Hochstufung | Needham | Hold → Buy |
| 2019-01-31 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | Bestätigt | FBR & Co. | Outperform |
| 2016-09-13 | Bestätigt | FBR Capital | Outperform |
| 2015-12-07 | Bestätigt | Piper Jaffray | Overweight |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-06-12 | Hochstufung | MLV & Co | Hold → Buy |
| 2014-03-12 | Herabstufung | MLV & Co | Buy → Hold |
| 2013-12-10 | Bestätigt | MLV & Co | Buy |
| 2013-12-10 | Hochstufung | Needham | Hold → Buy |
| 2013-11-08 | Bestätigt | MLV & Co | Buy |
| 2013-10-16 | Eingeleitet | MLV & Co | Buy |
| 2012-08-30 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-06-28 | Eingeleitet | Needham | Hold |
Alle ansehen
Geron Corp Aktie (GERN) Neueste Nachrichten
First Turn Management LLC Purchases Shares of 3,124,967 Geron Co. (NASDAQ:GERN) - MarketBeat
RA Capital Management's Strategic Acquisition of Geron Corp Shar - GuruFocus.com
Deep Track Capital's Strategic Reduction in Geron Corp Holdings - GuruFocus.com
RTW INVESTMENTS, LP Acquires New Stake in Geron Corp - GuruFocus.com
GERNGeron Corp Latest Stock News & Market Updates - StockTitan
Geron Strengthens Leadership: Top Oncology Expert Dr. Eid Joins as EVP of R&D | GERN Stock News - StockTitan
Geron to Present at Stifel 2024 Healthcare ConferenceKey Management Insights Coming | GERN Stock News - StockTitan
B. Riley Predicts Geron's FY2026 Earnings (NASDAQ:GERN) - MarketBeat
Equities Analysts Offer Predictions for Geron Q2 Earnings - MarketBeat
HC Wainwright Weighs in on Geron's Q1 Earnings (NASDAQ:GERN) - MarketBeat
Geron to Participate in the Stifel 2024 Healthcare Conference - Yahoo Finance
Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Q3 2024 Earnings Call Transcript - Insider Monkey
Geron Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ... By GuruFocus - Investing.com Canada
Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytel - GuruFocus.com
Geron Secures $250M Funding and Strong Q3 Sales - Yahoo Finance
Geron Corporation’s Q3 2024: Strong RYTELO Launch and Financial Growth - TipRanks
Geron started at buy by H.C. Wainwright ahead of Q3 earnings - MSN
Geron: Q3 Earnings Snapshot - Houston Chronicle
Geron (GERN) Q3 2024 Earnings Call Transcript - Barchart
Geron (NASDAQ:GERN) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Geron: A Post Earnings And Funding Announcement Assessment (NASDAQ:GERN) - Seeking Alpha
Geron earnings beat by $0.04, revenue topped estimates - Investing.com
Royalty Pharma to acquire royalty interest in Geron’s RYTELO for $125M - TipRanks
Geron price target raised to $9 from $8 at H.C. Wainwright - TipRanks
Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Geron spikes after Q3 beat and $375M funding deal - MSN
Geron sees FY24 operating expenses $260M-$270M - TipRanks
What is HC Wainwright's Estimate for Geron Q4 Earnings? - MarketBeat
Geron secures up to $375 million in financing - Investing.com
Geron stock spikes on Q3 beat and funding deal (GERN:NASDAQ) - Seeking Alpha
Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Geron’s (GERN) RYTELO for $125M - StreetInsider.com
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million - StockTitan
Geron Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Bakersfield Californian
Geron Secures Massive $375M Financing Deal for RYTELO Launch, Backed by Royalty Pharma | GERN Stock News - StockTitan
Brokerages Set Geron Co. (NASDAQ:GERN) Price Target at $7.05 - MarketBeat
HC Wainwright Estimates Geron's Q3 Earnings (NASDAQ:GERN) - MarketBeat
H.C. Wainwright: 'Rytelo off to a strong launch,' assigns Buy to Geron shares - Investing.com
Analyst Ratings For Geron - Benzinga
Geron's RYTELO Shows Strong Clinical Results in MDS Patients Ahead of ASH Meeting | GERN Stock News - StockTitan
HC Wainwright Begins Coverage on Geron (NASDAQ:GERN) - MarketBeat
Geron initiated with a Buy at H.C. Wainwright - TipRanks
abrdn plc Acquires New Position in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron (GERN) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
Is Geron (NASDAQ:GERN) Using Too Much Debt? - Simply Wall St
B.Riley sets Geron stock target, sustains Buy on strong Rytelo sales - Investing.com
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 17, 2024 - BioSpace
Geron (NASDAQ:GERN) Receives New Coverage from Analysts at Scotiabank - MarketBeat
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? - Insider Monkey
Finanzdaten der Geron Corp-Aktie (GERN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.42%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):